首页> Neurocritical care> Description of STRIVE-ON Study Protocol: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): A Prospective, Randomized, Phase III Trial (STRIVE-ON).

Description of STRIVE-ON Study Protocol: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): A Prospective, Randomized, Phase III Trial (STRIVE-ON).

导出 OA

翻译打印收藏纠错

第一作者： Alex H,Choi

第一单位： Division of Neurocritical Care, Department of Neurosurgery, UTHealth Houston, Houston, TX, USA.

作者： Alex H,Choi ^[1] ; Sherry Y,Chou ^[2] ; Andrew F,Ducruet ^[3] ; W Taylor,Kimberly ^[4] ; R,Loch Macdonald ^[5] ; Alejandro A,Rabinstein ^[6]

作者单位： Division of Neurocritical Care, Department of Neurosurgery, UTHealth Houston, Houston, TX, USA. ^[1] Division of Neurocritical Care, The Ken and Ruth Davee Department of Neurology, Northwestern Feinberg School of Medicine, Chicago, IL, USA. ^[2] Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA. ^[3] Division of Neurocritical Care, Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA. ^[4] Community Regional Medical Center, Community Neurological Institute and Community Health Partners, Fresno, CA, USA. l.macdonald@gracetx.com. ^[5] Department of Neurology, Mayo Clinic, Rochester, MN, USA. ^[6]

关键词 Calcium channel antagonist Cerebral aneurysm Cerebral vasospasm Clinical trial Delayed cerebral ischemia Nimodipine Subarachnoid hemorrhage